申请人:A. Nattermann & Cie GmbH
公开号:US04418069A1
公开(公告)日:1983-11-29
The present invention is related to new benzisoselenazolones having the general formula I ##STR1## new products having the general formula II ##STR2## used as intermediary products in the production of the compounds of formula I and a method for the treatment of rheumatic diseases using a compound of formula I as active agent.
本发明涉及具有一般式I的新苯并异硒唑酮,新产品具有一般式II,用作I式化合物的中间体,并使用I式化合物作为活性剂治疗风湿病的方法。